首页|黄柏酮抗脓毒症潜在靶点的筛选与鉴定

黄柏酮抗脓毒症潜在靶点的筛选与鉴定

扫码查看
目的 研究黄柏酮的分子特性,筛选并鉴定黄柏酮抗脓毒症的潜在靶点。方法 通过中药系统药理学数据库分析平台(TCMSP)分析黄柏酮的药理参数和分子特性;通过化合物靶标预测平台工具SwissTargetPrediction服务器和化学成分靶向蛋白服务器(DRAR-CPI),以Z'值<-0。5筛选黄柏酮抗脓毒症的潜在靶点;通过人类孟德尔遗传在线(OMIM)数据库、毒性与基因比较数据库(CTD)和药物靶标数据库(TTD)中已报道的蛋白信息与脓毒症相关疾病靶标进行匹配,筛选黄柏酮抗脓毒症的靶点;进一步通过分子对接软件鉴定黄柏酮抗脓毒症的潜在靶点。结果 黄柏酮口服生物利用度(OB)为81。58%,药物相似度(DL)为0。57,表明其口服吸收较好,具有很好的成药性。通过SwissTargetPrediction和DRAR-CPI服务器共筛选到242个黄柏酮抗脓毒症的潜在靶点,其中有13个靶点与脓毒症直接相关。经分子对接软件鉴定,组织蛋白酶G(CTSG)、胱天蛋白酶1(CASP1)、S100钙结合蛋白A9(S100A9)、蛋白C(凝血因子Ⅴa和Ⅷa抑制因子,PROC)、丝裂素活化蛋白激酶1(MAPK1)、葡萄糖-6-磷酸脱氢酶(G6PD)、白细胞介素-10(IL-10)、巨噬细胞移动抑制因子(MIF)、C5a受体1(C5AR1)、胱天蛋白酶3(CASP3)、CXC趋化因子受体2(CXCR2)、凝血酶受体(F2R)和烟酰胺磷酸核糖转移酶(NAMPT)为黄柏酮抗脓毒症的潜在靶点,自由结合能分别为-32。55、1。26、-30。00、300。08、-31。88、-30。29、-21。38、-30。79、16777。84、-21。80、6443。36、-20。38、-23。47 kJ/mol。结论 黄柏酮通过调控PROC和F2R抑制凝血并改善炎症反应;调节MIF、S100A9、G6PD和IL-10起到免疫应答作用;调节CTSG、CASP1、MAPK1、C5AR1和CASP3起到保护脓毒症损伤器官的作用;调控CXCR2减少中性粒细胞向炎症部位过度迁移,减轻组织损伤;调控NAMPT改善细胞能量状态,减少氧化应激从而保护细胞不受损害,并通过减轻脓毒症的症状和炎症反应来发挥其抗脓毒症的作用。
Optimization and identification of potential targets of obacunone against sepsis
Objective To investigate the molecular characteristics of obacunone,and to screen and identify potential targets of obacunone against sepsis.Methods The pharmacological parameters and molecular characteristics of obacunone were analyzed with the aid of the Traditional Chinese Medicine Systems Pharmacology Database Analysis Platform(TCMSP).The potential targets of obacunone against sepsis were screened using SwissTargetPrediction and Drug Repositioning and Adverse Drug Reaction Chemical-Protein Interactome(DRAR-CPI)software,with a Z'-score<-0.5.The anti-sepsis targets of obacunone were selected by Online Mendelian Inheritance in Man(OMIM),Comparative Toxicogenomics Database(CTD)and Therapeutic Target Database(TTD).The anti-sepsis potential target was identified by molecular docking software.Results The oral bioavailability of obacunone was 81.58%and the drug-likeness was 0.57 indicating that obacunone showed good drug formation.A total of 242 potential targets were screened through SwissTargetPrediction and DRAR-CPI software,13 targets were directly related to sepsis.Cathepsin G(CTSG),caspase-1(CASP1),S100 calcium binding protein A9(S100A9),protein C(inactivator of coagulation factorsⅤa and Ⅷ a,PROC),mitogen-activated protein kinase 1(MAPK1),glucose-6-phosphate dehydrogenase(G6PD),interleukin-10(IL-10),migration inhibitory factor(MIF),complement C5a receptor 1(C5AR1),caspase-3(CASP3),CXC chemokine receptor 2(CXCR2),thrombin receptor(F2R),nicotinamide phosphoribosyltransferase(NAMPT)were identified as the potential targets for anti-sepsis of obacunone by molecular docking software,the free binding energies were-32.55,1.26,-30.00,300.08,-31.88,-30.29,-21.38,-30.79,16 777.84,-21.80,6 443.36,-20.38,-23.47 kJ/mol,respectively.Conclusions Obacunone can inhibit blood coagulation and improve inflammatory response by regulating PROC and F2R.It regulates MIF,S100A9,G6PD and IL-10 to play a role in immune response.It regulates CTSG,CASP1,MAPK1,C5AR1 and CASP3 to protect sepsis-damaged organs.By regulating CXCR2,it can reduce the excessive migration of neutrophils to the site of inflammation,alleviate tissue damage.By regulating NAMPT,it improves cellular energy status,reduces oxidative stress,and protects cells from damage.

ObacunonePotential targetInflammationSepsis

陈玉婷、刘雨浓、刘畅、徐煜彬、陈桂荣

展开 >

辽宁中医药大学药学院,辽宁大连 116600

台州市中心医院(台州附属医院)药剂科,浙江台州 318000

黄柏酮 潜在靶点 炎症 脓毒症

国家自然科学基金辽宁省应用基础研究计划项目

823740082022JH2/101300081

2024

中华危重病急救医学
中华医学会

中华危重病急救医学

CSTPCD北大核心
影响因子:3.049
ISSN:2095-4352
年,卷(期):2024.36(8)